Skip to main content

Table 2 Participants’ European Quality of Life visual analogue scores by sociodemographic and clinical characteristics

From: The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine

Variable

Frequency (%); N = 300

Median [Q1-Q3]

P valuea

Age category (years)

   

Less than 60

182 (60.7)

70 [50–80]

< 0.001b

60 or more

118 (39.3)

50 [29–70]

 

Gender

   

Male

166 (35.3)

60 [50–75]

0.429b

Female

134 (44.7)

66 [40–77]

 

Body mass index category

   

Underweight

12 (4.0)

70 [25–88]

0.003c

Healthy

96 (32.0)

70 [50–80]

 

Overweight

113 (37.7)

60 [40–80]

 

Obese

79 (26.3)

50 [35–70]

 

Residency

   

Refugee camp

30 (10.0)

75 [38–81]

0.141c

Village

175 (58.3)

63 [50–75]

 

City

95 (31.7)

60 [30–75]

 

Living arrangement

   

Alone

19 (6.3)

70 [50–75]

0.269b

With family

281 (93.7)

60 [40–75]

 

Educational level

   

No formal education

14 (4.7)

48 [18–71]

 < 0.001c

Primary school

62 (20.7)

50 [30–70]

 

Secondary school

81 (27.0)

60 [40–77]

 

High school

67 (22.3)

60 [50–75]

 

Graduated

76 (25.3)

70 [55–84]

 

Social status

   

Married

220 (73.3)

60 [44–75]

0.729b

Single, divorced, or widowed

80 (26.7)

70 [31.2–80]

 

Employment

   

Unemployed

235 (78.3)

60 [40–70]

 < 0.001b

Employed

65 (21.7)

75 [60–87]

 

Household monthly income

   

< 2000 NIS

178 (59.3)

60 [39–75]

0.001c

2000–4999 NIS

109 (36 .3)

65 [48–80]

 

> 5000 NIS

13 (4.3)

78 [70–85]

 

Dialysis vintage(years)

   

< 4

196 (65.3)

65 [41–78]

0.040b

≥ 4

104 (34.7)

58 [31–75]

 

Dialysis sessions per week

   

< 3

21 (7.0)

65 [53–73]

0.787c

3

276 (92.0)

60 [40–77]

 

≥ 4

3 (1.0)

75 [50-N/A]

 

Dialysis session duration (hours)

   

< 4

258 (86.0)

65 [40–77]

0.740b

≥ 4

42 (14.0)

60 [50–71]

 

Previous kidney transplantation

   

Yes

13 (4.3)

80 [40–78]

0.258b

No

287 (95.7)

60 [40–75]

 

Known cause for ESRD

   

Yes

281 (93.7)

65 [40–78]

0.439b

No

19 (6.3)

60 [40–70]

 

Chronic diseases category

   

None

30 (10.0)

75 [50–89]

< 0.001c

1

77 (25.7)

70 [50–80]

 

2

86 (28.7)

65 [50–79]

 

≥ 3

107 (35.7)

50 [20–70]

 

Chronic medications category

   

< 4

10 (3.3)

50 [28–59]

0.037b

≥ 4

290 (96.7)

65 [40–77]

 

Smoking

   

Nonsmoker

218 (72.7)

65 [40–75]

0.439c

Light smoker

48 (16.0)

55 [50–80]

 

Smoker

34 (11.3)

68 [50–82]

 

Pain severity

   

Mild

219 (73.0)

70 [50–80]

< 0.001c

Moderate

38 (12.7)

50 [35–61]

 

Severe

34 (14.3)

12 [10–40]

 

Pain interference

   

Low

241 (80.3)

70 [50–80]

< 0.001b

High

59 (19.7)

20 [10–50]

 
  1. ESRD, end stage renal disease; NIS, New Israeli shekel (1 NIS = 0.31 US Dollars)
  2. aBold values denote statistical significance at the p < 0.05 level
  3. bMann–Whitney U test
  4. cKruskal–Wallis test